天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

3-甲基腺嘌呤,3-Methyladenine

3-甲基腺嘌呤|T1879主打

價(jià)格 449 668 1160
包裝 50mg 100mg 200mg
最小起訂量 1mg
發(fā)貨地 上海
更新日期 2024-12-02
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:3-甲基腺嘌呤英文名稱:3-Methyladenine
CAS:5142-23-4品牌: TargetMol
產(chǎn)地: 美國(guó)保存條件: store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | Shipping with blue ice.
純度規(guī)格: 99.51%產(chǎn)品類(lèi)別: 抑制劑
貨號(hào): T1879
2024-12-02 3-甲基腺嘌呤 3-Methyladenine 50mg/449RMB;100mg/668RMB;200mg/1160RMB 449 TargetMol 美國(guó) store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | Shipping with blue ice. 99.51% 抑制劑

Product Introduction

Bioactivity

名稱3-Methyladenine
描述3-Methyladenine (3-MA) is a PI3K inhibitor that selectively inhibits class IB PI3Kγ (IC50=60 μM) and class III VPS34 (IC50=25 μM). 3-Methyladenine inhibits autophagy.
細(xì)胞實(shí)驗(yàn)Cells were seeded in an 8-well coverglass-bottomed chamber for 24 hours (6×10^3 cells per well). Images were acquired automatically at multiple locations on the coverglass using a Nikon TE2000E inverted microscope fitted with a 20× Nikon Plan Apo objective, a linearly-encoded stage, and a Hamamatsu Orca-ER CCD camera. A mercury-arc lamp with two neutral density filters (for a total 128-fold reduction in intensity) was used for fluorescence illumination. The microscope was controlled using NIS-Elements Advanced Research software and housed in a custom-designed 37°C chamber with a secondary internal chamber that delivered humidified 5% CO2. Fluorescence and differential interference contrast images were obtained every 10 min for a period of 48 hours. To analyze live cell imaging movies, the time-lapse records of live cell imaging experiments were exported as an image series and analyzed manually using NIS-Elements Advanced Research software. The criteria for analyses were described previously, and lagging chromosomes in prometaphase were defined as the red fluorescence-positive materials that lingered outside the roughly formed metaphase plate for more than 3 frames (30 min) [2].
動(dòng)物實(shí)驗(yàn)All rats were fasted for 12 h with free access to water prior to operation. After anesthesia by intraperitoneal (i.p.) injection of 2% sodium pentobarbital (0.25 mL/100 g), they were laid and fixed on the table, routinely shaven, disinfected, and draped. The rat SAP model was induced by 0.1 mL/min speed uniformly retrograde infusion of a freshly prepared 3.5% sodium taurocholate solution (0.1 mL/100 g) into the biliopancreatic duct after laparotomy. Equivalent volume of normal saline solution was substituted for 3.5% sodium taurocholate solution in the sham-operation (SO) control group. The incision was closed with a continuous 3-0-silk suture, and 2 mL/100 g of saline was injected into the back subcutaneously to compensate for the fluid loss. 180 rats were randomly divided into four groups: (1) Acanthopanax treatment group (Aca group, n = 45) where the rats were injected with 0.2% Acanthopanax injection at a dose of 3.5 mg/100 g 3 h after successful modeling via the vena caudalis once, knowing that this dosage was effective as proven in our previous experiment; (2) 3-Methyladenine treatment group (3-methyladenine group, n = 45) where the rats were injected with 100 nmol/μL 3-methyladenine solution at a dose of 1.5 mg/100 g 3 h after successful modeling via the intraperitoneal route once, knowing that this dosage was effective as proven in the literature [6]; (3) SAP model group (SAP group, n = 45) where these rats received an equivalent volume of the normal saline instead of Acanthopanax injection 3 h after successful modeling via the vena caudalis once; (4) SO group (control, n = 45) where these rats received an equivalent volume of the normal saline instead of Acanthopanax injection 3 h after successful sham-operation via the vena caudalis once. The 45 animals in each of the four groups were equally randomized into 3, 12, and 24 h subgroups for postoperative observations [4].
體外活性方法:人宮頸癌細(xì)胞 HeLa 用 3-Methyladenine (2.5-10 mM) 處理 48 h,使用 Trypan blue dye exclusion assay 檢測(cè)細(xì)胞生長(zhǎng)抑制情況。 結(jié)果:3-Methyladenine 以時(shí)間和劑量依賴的方式降低 HeLa 細(xì)胞活力。[1] 方法:脂肪細(xì)胞 3T3-L1 在沒(méi)有血清的情況下用 3-Methyladenine (5 mM) 處理 4 h,使用 Western Blot 方法檢測(cè)靶點(diǎn)蛋白表達(dá)水平。 結(jié)果:3-Methyladenine 顯著降低了自噬標(biāo)記物 LC3-II 的細(xì)胞內(nèi)水平,增加了 p62 的表達(dá),表明 3-Methyladenine 有效抑制自噬。[2] 方法:小鼠黑色素瘤細(xì)胞 B16 用 2DG (5 mM)、rotenone (1 μM) 和 3-Methyladenine (1.2-5 mM) 處理 24 h,使用 LDH release assay 檢測(cè)細(xì)胞毒性。 結(jié)果:3-Methyladenine 劑量依賴性降低 2DG/rotenone 引起的 LDH 釋放上調(diào),保護(hù)腫瘤細(xì)胞免受糖酵解和線粒體呼吸抑制。[3]
體內(nèi)活性方法:為研究 3-Methyladenine 對(duì)動(dòng)脈粥樣硬化的影響,將 3-Methyladenine (30 mg/kg) 腹腔注射給 HFD 喂養(yǎng)的 ApoE?/? 小鼠,每周兩次,持續(xù)八周。 結(jié)果:在高脂肪飲食喂養(yǎng)的小鼠中, 3-Methyladenine 治療顯著減少了動(dòng)脈粥樣硬化斑塊的大小,并增加了病變的穩(wěn)定性。3-Methyladenine 具有多種動(dòng)脈粥樣硬化保護(hù)作用,包括調(diào)節(jié)巨噬細(xì)胞自噬和泡沫細(xì)胞形成以及改變免疫微環(huán)境。[4] 方法:為研究自噬的調(diào)節(jié)作用,將 3-Methyladenine (15 mg/kg?) 單劑量腹腔注射給 LPS 誘導(dǎo)內(nèi)毒素休克的 C57/BL6 小鼠。 結(jié)果: LPS 聯(lián)合 3-Methyladenine 治療的動(dòng)物在內(nèi)毒素血癥后表現(xiàn)出存活率增加,血清炎癥介質(zhì) TNF-α 和 IL-6 降低。[5]
存儲(chǔ)條件store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | Shipping with blue ice.
溶解度DMSO : 13.75 mg/mL (92.19 mM), Heating is recommended.(The compound is unstable in solution, please use soon.)
Ethanol : 4 mg/mL (26.81 mM)
H2O : 3 mg/mL (20.11 mM), Sonication and heating are recommended. (The compound is unstable in solution, please use soon.)
關(guān)鍵字3 Methyladenine | inhibit | Mitochondrial Autophagy | 3Methyladenine | NSC66389 | PI3K | Endogenous Metabolite | 3-Methyladenine | Mitophagy | Autophagy | NSC-66389 | Phosphoinositide 3-kinase | Inhibitor
相關(guān)產(chǎn)品Guanidine hydrochloride | Naringin | Daidzein | Glycerol | Sucrose | Hydroxychloroquine | Ferulic Acid | 3-Indoleacetic acid | Stavudine | Thymidine | Paeonol | Fumaric acid
相關(guān)庫(kù)核苷類(lèi)化合物庫(kù) | 抗結(jié)直腸癌化合物庫(kù) | HIF-1化合物庫(kù) | 抗卵巢癌化合物庫(kù) | 干細(xì)胞分化化合物庫(kù) | 糖代謝化合物庫(kù) | 抗代謝疾病化合物庫(kù) | 銅死亡化合物庫(kù) | 高通量篩選天然產(chǎn)物庫(kù) | Ro5類(lèi)藥天然產(chǎn)物庫(kù) | 神經(jīng)元分化化合物庫(kù) | PI3K/Akt/mTOR 化合物庫(kù)
關(guān)鍵字: NSC 66389|||3-甲基腺嘌呤|||3-MA|TargetMol

公司簡(jiǎn)介

上海陶術(shù)生物科技有限公司為美國(guó)Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國(guó)波士頓、德國(guó)慕尼黑的同事一起,為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專(zhuān)業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部,化學(xué)事業(yè)部,生物事業(yè)部和新材料部。 從虛擬篩選到實(shí)體化合物分子供應(yīng);從商業(yè)化產(chǎn)品銷(xiāo)售到個(gè)性化定制合成;從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選,從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化,我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。 經(jīng)過(guò)在中國(guó)市場(chǎng)五年的精心耕耘,我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商,為超過(guò)五百家學(xué)校和各類(lèi)企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩
成立日期 2013-04-18 (12年) 注冊(cè)資本 566.2651萬(wàn)人民幣
員工人數(shù) 100-500人 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 化學(xué)試劑,生物活性小分子 經(jīng)營(yíng)模式 貿(mào)易,試劑,定制,服務(wù)
  • TargetMol中國(guó)(陶術(shù)生物)
VIP 12年
  • 公司成立:12年
  • 注冊(cè)資本:566.2651萬(wàn)人民幣
  • 企業(yè)類(lèi)型:有限責(zé)任公司(自然人投資或控股)
  • 主營(yíng)產(chǎn)品:小分子抑制劑,藥物篩選化合物庫(kù),天然產(chǎn)物,活性分子化合物等
  • 公司地址:上海市閘北區(qū)江場(chǎng)三路28號(hào)4樓
詢盤(pán)

3-甲基腺嘌呤|T1879相關(guān)廠家報(bào)價(jià)

更多
產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
VIP5年
武漢華玖醫(yī)藥科技有限公司
2024-12-27
¥700.00
VIP9年
北京索萊寶科技有限公司
2024-12-27
詢價(jià)
VIP6年
上海澤葉生物科技有限公司
2024-12-27
詢價(jià)
VIP4年
四川省維克奇生物科技有限公司
2024-12-27
詢價(jià)
VIP4年
武漢艾美捷科技有限公司
2024-12-20
詢價(jià)
VIP3年
陜西締都醫(yī)藥化工有限公司
2024-12-18
¥145.90
VIP1年
上海阿拉丁生化科技股份有限公司
2024-11-29
¥298.90
VIP13年
上海阿拉丁生化科技股份有限公司
2024-10-31
¥500
南京百鑫德諾生物科技有限公司
2024-09-26
詢價(jià)
湖北麥凱斯精化科技有限公司
2023-03-23
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買(mǎi)數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的